Fortis Healthcare Ltd
Fortis Healthcare Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹2,735Cr
- Net profit
- ₹320Cr
- Margin
- 22.8%
Guidance rank: #30 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Fortis Healthcare Ltd Q2 FY27 key numbers
- Revenue
- Q2FY27 consolidated revenue: INR 2,735 Cr, up 17.3% YoY (Q2FY26: INR 2,331 Cr).
As stated in Fortis Healthcare Ltd's Q2 FY27 investor presentation · published 5 Nov 2026. Reported figures, not investment advice.
Based on Fortis Healthcare Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2FY27 consolidated revenue: INR 2,735 Cr, up 17.3% YoY (Q2FY26: INR 2,331 Cr) [Pages 11, 33]. Q2FY27 EBITDA: INR 629.9 Cr with a margin of 23.0% (up from 24.8% margin in Q2FY26; margin slightly down).
From Fortis Healthcare Ltd's Q2 FY27 earnings-call transcript · updated 5 Nov 2026.
How did Fortis Healthcare's revenue grow in the September 2026 quarter?
- Q2FY27 consolidated revenue: INR 2,735 Cr, up 17.3% YoY (Q2FY26: INR 2,331 Cr) [Pages 11, 33]
- Hospital business Q2FY27 operating revenue: INR 2,340 Cr, up 18.6% YoY (Q2FY26: INR 1,974 Cr) [Page 16]
- Diagnostics business Q2FY27 gross revenue: INR 448 Cr, up 12.2% YoY (Q2FY26: INR 400 Cr) [Pages 15, 17]
2 more points from Fortis Healthcare Ltd's call on revenue
Create a free account to keep reading this call
What happened to Fortis Healthcare's margins in Q2 FY27?
See what Fortis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
What capex is Fortis Healthcare planning?
- Fortis aims to reach ~12,000 beds over the next 3-5 years.
- Current bed capacity is ~6,300 with ~1,900 from brownfield expansion and ~1,600 from inorganic opportunities, totaling ~2,200 additional beds.
- O&M expansion includes HSA with SLJ Society, additional capacity at Gleneagles units, and greenfield facilities at Lucknow and Cuttack.
2 more points from Fortis Healthcare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Fortis Healthcare raising money or cutting debt?
See what Fortis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Fortis Healthcare's order book?
See what Fortis Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Fortis Healthcare Ltd — Quarterly revenue & net profit
Fortis Healthcare Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 2,735 |
| Operating profit (EBITDA) | 623 |
| Operating margin | 22.8% |
| Profit before tax | 426 |
| Net profit (PAT) | 320 |
| EPS (₹) | 4.14 |
Source: Fortis Healthcare Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.7K Cr, net profit ₹320 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fortis Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- Nidan Laboratories & Healthcare (Q2 FY27)
Operating Margin: Not explicitly stated as a percentage; however, total income from operations is Rs 1,201.76 lakhs, so approximate operating margin = (EBITDA…
- Suven Life Sciences (Q2 FY27)
91.92 lakhs for the quarter ended September 30, 2025, indicating a revenue increase of approximately 30.3%. Key results statement takeaways from Suven Life Scie
- Aster DM Quality (Q2 FY27)
Q2 FY27 revenue: INR 2,829 Cr, up 19% YoY from INR 2,382 Cr in Q2 FY26 (Page 6, 9, 10). Key investor presentation takeaways from Aster DM Quality Care Ltd's Q2
- Dr Agarwal's Hea (Q2 FY27)
Q2 FY27 revenue from operations: ₹655 Cr, up 31.4% YoY from ₹499 Cr in Q2 FY26 (Page 24) . Key investor presentation takeaways from Dr Agarwals Health Care Ltd'
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fortis Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fortis Healthcare Ltd Q2 FY27 results?
Q2FY27 consolidated revenue: INR 2,735 Cr, up 17.3% YoY (Q2FY26: INR 2,331 Cr) [Pages 11, 33]. Q2FY27 EBITDA: INR 629.9 Cr with a margin of 23.0% (up from 24.8% margin in Q2FY26; margin slightly down).
What is Fortis Healthcare Ltd share price analysis?
Fortis Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 58.0 with a market cap of ₹61,891 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fortis Healthcare Ltd planning capital expenditure?
Fortis aims to reach ~12,000 beds over the next 3-5 years.
Keep Fortis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.